Cytokinetics is committed to supporting patients with MYQORZO & You™, a personalized program for patients prescribed MYQORZO ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incor ...

The HELIOS-B trial previously showed that vutrisiran (Amvuttra; Alnylam Pharmaceuticals), a gene-silencing therapy that ...

Which exercises are most effective for your pecs? What to know.

Nonpharmacologic heart failure management and interventions can reduce cardiovascular risk factors and carotid intima-media ...

Different fibrotic interstitial lung diseases share demographic and functional similarities despite having different causes.

Africa’s long-term educational outcomes are tied to its broader development trajectory. Experts at the unveiling of ...

Carda Health, a leader in at-home virtual pulmonary and cardiac care, announced today a first-of-its-kind partnership with ...

There are many ways to show your special someone you care. But if you need ideas, these Valentine’s Day sales on thoughtful, ...

Residents have called for a new Stranraer station since the ferry terminal it served shut in 2011.

Background International guidelines recommend percutaneous coronary intervention within 120 min for high-risk acute coronary syndrome. In Indonesia, a sprawling archipelago with a rising ...